Latest News Archive

Please select Category, Year, and then Month to display items

Biggest honour of her life, says Comrades winner

10 June 2019 | Story Ruan Bruwer | Photo Gerda Steyn Twitter

Winning the Comrades ultra-marathon is the greatest honour of her life and still feels unreal, said Gerda Steyn a day after winning the race in a record time.

The former Kovsie student had an incredible race on Sunday, completing the 86,83 km’s in a time of 05:58:54, which is a new record for women in the up run. It is more than 10 minutes faster than the previous record of 06:09:23 set in 2006.

It was also the fourth fastest Comrades time ever by a female in the 94-year history of the race.

Greatest honour of my life

“Being the Comrades winner is the greatest honour of my life. Thank you to an entire nation for carrying me to the line. It feels like a dream,” Steyn said.

The 29-year-old Steyn became the first woman in 30 years to win both the Comrades and Two Oceans in the same year. She also won the Two Oceans in 2018 and came second in the Comrades last year.

Steyn, who studied Quantity Surveying and Construction Management at the University of the Free State (UFS) between 2009 and 2012, said the record time was discussed beforehand.

I went for it

“We felt it was possible, but it wasn’t my main goal right from the start of the race. At the halfway mark, I saw it was possible and I went for it.”

According to Steyn, the media attention since her win is quite intense. “But I don’t complain. It is such an honour, so I do it with a smile.”

At the Two Oceans ultra-marathon in April, she missed out on the 30-year record time by just 53 seconds.

Prof Francis Petersen, UFS Rector and Vice-Chancellor, said Steyn was a proud ambassador of the university. “It is always important for me to see how our former students perform. I would like to congratulate her. Well done. She is carrying the Kovsie name with pride,” Prof Petersen said.

News Archive

New research informs improved treatment of brain inflammation

2017-10-13

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish

Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept